Engineered Extracellular Vesicles in Arthritic Diseases: Therapeutic Applications & Challenges

Area of Science:

• Biomaterials Science
• Regenerative Medicine
• Nanotechnology

Background:

• Arthritic diseases pose a significant global health challenge, necessitating novel therapeutic approaches.
• Extracellular vesicles (EVs) are emerging as potent therapeutic agents for intractable diseases.
• Joint diseases, particularly Osteoarthritis (OA), represent a key area for EV-based interventions.

Purpose of the Study:

• To review the therapeutic potential of engineered extracellular vesicles (EVs) for joint diseases.
• To compare the efficacy of EVs with their parental stem cells in treating joint conditions.
• To explore strategies for engineering EVs to overcome limitations of natural EVs.

Main Methods:

• Analysis of preclinical trials, clinical studies, and in vitro/in vivo reports on EV therapy for joint diseases.
• Evaluation of EV engineering strategies to enhance therapeutic efficacy.
• Review of the biomolecular cargo of EVs, including proteins, microRNAs, lipids, and nucleic acids.

Main Results:

• Recent research confirms the efficacy of EVs in treating joint diseases, especially OA.
• EVs exhibit crucial roles in intercellular communication, bone remodeling, cartilage regeneration, immunomodulation, and inflammation control.
• EVs possess a rich biomolecular composition that enhances their therapeutic potential compared to parental stem cells.

Conclusions:

• Engineered EVs offer a promising avenue for developing targeted and effective therapies for OA and other joint diseases.
• A comprehensive understanding of EV engineering and their underlying mechanisms is vital for advancing novel treatments for arthritic conditions.
• EVs represent a significant leap forward in nanotechnology for tissue repair and replacement.